The BC Academic Health Science Network (BC AHSN) is pleased to provide the following update on current activities within the BC AHSN organization, which includes Clinical Trials BC and the BC SUPPORT Unit.
Our update on activities for the month of October includes:
- BC AHSN supports Diabetes Data Linkage Initiative
- Great opportunities with Rewarding Success
- Countdown to BC SUPPORT Unit provincial conference
- Preparing for new clinical research regulations
- Plan today for SoCRA certification in 2018
- Recruitment: Methods Cluster Lead
- Stakeholders respond to BC Patient-Oriented Research Survey
- Clinical Trials BC around the province
Provincial work towards a proposal for Digital Transformation Canada as a BC-hosted supercluster has created an opportunity for a use case related to health system priorities that showcases how collaboration, data use and learning across multiple stakeholders and sectors can be leveraged.
The Diabetes Data Linkage Initiative is a BC Ministry of Health/BC AHSN initiative to advance the integration of provincial diabetes datasets to accelerate care, research and innovation. This project will also serve as an illustrator and accelerator of BC’s ability to capitalize on data assets.
The BC AHSN Board has confirmed its support for Phase 1 of this initiative, which focuses on: building a diabetes data inventory; identifying relevant data sets and data gaps; conducting an environmental scan; and summarizing learnings in Canada and other jurisdictions that have demonstrated a data-driven approach to diabetes management.
Phase 1 will also include designing a project framework, which will identify the project governance structure, key partners and stakeholders, as well as developing a high-level implementation plan with anticipated budget and timelines to carry the framework forward into action (Phase 2). BC AHSN’s key assessment criteria for priority initiatives will guide and inform the framework design and implementation plan.
Decisions around further BC AHSN support for Phase 2 will be based on review of this implementation plan.
Rewarding Success is a new funding initiative led by the Canadian Institutes of Health Research through the Strategy for Patient-Oriented Research (SPOR). This multi-phased experimental funding model is being piloted in four provinces: BC, Alberta, Manitoba, and Newfoundland & Labrador.
The BC SUPPORT Unit is partnering with CIHR to coordinate this initiative in BC and recently hosted an informational webinar with representatives from CIHR, the BC Ministry of Health and BC SUPPORT Unit management providing details about the initiative and how to apply. Applicants to the first phase of Rewarding Success will continue to be supported by the BC SUPPORT Unit team.
In addition, the BC AHSN Board recognizes the significant opportunity for accelerating broader network development and rollout by capitalizing on this program, with its similar focus on provincial health priorities and a multi-partner, multi-sector approach to delivering health system interventions. Planning is underway to confirm BC AHSN support for this initiative.
The BC SUPPORT Unit’s inaugural provincial conference promises valuable opportunities for stakeholders to learn, share ideas and make personal connections that enhance their involvement in patient-oriented research. More than 300 registrants have signed up so far for Putting Patients First: Partnerships for Better Health Research on November 9th in downtown Vancouver. The event features eight unique breakout sessions, more than 40 speakers, and 24 research teams with posters about their work. Learn more here.
The International Conference on Harmonisation (ICH) guidance E6 (R2): Good Clinical Practice (GCP) will come into full effect Canada-wide on April 1, 2018. It’s important that all clinical research professionals are up-to-date with their GCP training.
CITI-Canada’s online GCP courses have been updated to reflect the new regulations. Through Clinical Trials BC’s provincial membership with N2 Network of Networks, these courses are available without cost to all clinical researchers in BC working in health authorities and academic organizations, as well as independent investigators. There are nearly 4,000 learners in BC currently registered for CITI Canada’s online courses.
The time has never been better to consider getting your certification from the Society of Clinical Research Associates (SoCRA). Clinical Trials BC is offering reimbursement of 80% of the SoCRA certification exam fee for up to 25 clinical research professionals at BC-based academic research sites. The program is administered by the Centre for Health Evaluation and Outcome Sciences (CHÉOS) on behalf of Clinical Trials BC.
The process is simple: register for the SoCRA exam by December 22, 2017; submit your application for Clinical Trials BC reimbursement by January 5, 2018; get prepared through a series of CHÉOS-hosted study groups in January (offered in person or online), and take the exam on February 2, 2018 in Vancouver. Read an overview of the program.
The BC SUPPORT Unit is currently seeking a Lead for the Patient-Centred Measurement Methods Cluster.
The successful candidate will join an outstanding team of five other Methods Cluster Leads. The application deadline is November 15th, 2017 at 5:00pm. For more information, view the full posting here.
The BC SUPPORT Unit’s September survey on stakeholder training and resource needs attracted 114 responses from individuals representing the Unit’s four stakeholder groups (patients, researchers, health care providers and health system decision-makers). Results will be shared in a future issue of the BC AHSN newsletter and the BC SUPPORT Unit’s Bulletin.
As part of a renewed focus on province-wide outreach, Clinical Trials BC representatives have been busy over the last few months meeting with stakeholders in various regions and conducting presentations and workshops. Visits to the Island, Fraser, Northern and Interior health regions have built clinical research capacity and raised awareness about the services, support and resources available through Clinical Trials BC.